N@N

Flamel Technologies to Present at the UBS Global Life Sciences Conference in New York

_{//health-fitness.news-articles.net/content/2010/ .. global-life-sciences-conference-in-new-york.html}
^{Published in Health and Fitness on Monday, September 13th 2010 at 13:30 GMT by Market Wire}  

LYON, France--([ BUSINESS WIRE ])--Flamel Technologies(NASD: FLML) announced today that its chief executive officer, Stephen H. Willard, is scheduled to present at the UBS Global Life Sciences Conference on Monday, September 20^th at 12:30 PM. The presentation will be webcast and may be accessed at the Flamel Technologies website: [ www.flamel.com ]

This document contains a number of matters, particularly as related to the status of various research projects and technology platforms, that constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The document reflects the current view of management with respect to future events and is subject to risks and uncertainties that could cause actual results to differ materially from those contemplated in such forward-looking statements. These risks include risks that products in the development stage may not achieve scientific objectives or milestones or meet stringent regulatory requirements, uncertainties regarding market acceptance of products in development, the impact of competitive products and pricing, and the risks associated with Flamel's reliance on outside parties and key strategic alliances. We undertake no obligation to update these forward-looking statements as a result of new information, future events or otherwise.You should not place undue reliance on these forward-looking statements. For further information on the Company, please review Flamel's Annual Report on the Securities and Exchange Commission Form 20-F for the year ended December 31, 2009.